Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Mateusz, Gliwiński"'
Autor:
Samikshya Santosh Nirmala, Kayani Kayani, Mateusz Gliwiński, Yueyuan Hu, Dorota Iwaszkiewicz-Grześ, Magdalena Piotrowska-Mieczkowska, Justyna Sakowska, Martyna Tomaszewicz, José Manuel Marín Morales, Kavitha Lakshmi, Natalia Maria Marek-Trzonkowska, Piotr Trzonkowski, Ye Htun Oo, Anke Fuchs
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
The initial idea of a distinct group of T-cells responsible for suppressing immune responses was first postulated half a century ago. However, it is only in the last three decades that we have identified what we now term regulatory T-cells (Tregs), a
Externí odkaz:
https://doaj.org/article/ad7a91b69f724da59a68e02fb2a5ce33
Autor:
Mateusz Gliwiński, Magdalena Piotrowska, Dorota Iwaszkiewicz-Grześ, Zuzanna Urban-Wójciuk, Piotr Trzonkowski
Publikováno v:
Contemporary Oncology, Vol 23, Iss 1, Pp 1-6 (2019)
This review focuses on the role of regulatory T cells (Tregs) in the process of carcinogenesis. The controversy of this issue arose due to the increasing therapeutic use of Tregs in humans (inter alia, in the treatment of autoimmune diseases). It is
Externí odkaz:
https://doaj.org/article/13d0fd34776e4ab2a08be0f63aef6fa0
Autor:
Mateusz Gliwiński, Dorota Iwaszkiewicz-Grześ, Anna Wołoszyn-Durkiewicz, Monika Tarnowska, Magdalena Żalińska, Matylda Hennig, Hanna Zielińska, Anna Dukat-Mazurek, Joanna Zielkowska-Dębska, Maciej Zieliński, Anna Jaźwińska-Curyłło, Radosław Owczuk, Przemysława Jarosz-Chobot, Artur Bossowski, Agnieszka Szadkowska, Natalia Marek-Trzonkowska, Grażyna Moszkowska, Janusz Siebert, Małgorzata Myśliwiec, Piotr Trzonkowski
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
ObjectiveHere we looked for possible mechanisms regulating the progression of type 1 diabetes mellitus (T1DM). In this disease, autoaggressive T cells (T conventional cells, Tconvs) not properly controlled by T regulatory cells (Tregs) destroy pancre
Externí odkaz:
https://doaj.org/article/ab4857077c9e42efa4de41884a712ae6
Autor:
Maciej Zieliński, Magdalena Żalińska, Dorota Iwaszkiewicz‐Grześ, Mateusz Gliwiński, Matylda Hennig, Anna Jaźwińska‐Curyłło, Halla Kamińska, Justyna Sakowska, Anna Wołoszyn‐Durkiewicz, Radosław Owczuk, Wojciech Młynarski, Przemysława Jarosz‐Chobot, Artur Bossowski, Agnieszka Szadkowska, Janusz Siebert, Małgorzata Myśliwiec, Natalia Marek‐Trzonkowska, Piotr Trzonkowski
Publikováno v:
Diabetes, Obesity and Metabolism. 24:1534-1543
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97b888755ac3bebbcd9985e5b2c75d0e
https://doi.org/10.1111/dom.14723
https://doi.org/10.1111/dom.14723
Autor:
Anke Fuchs, Mateusz Gliwiński, Nathali Grageda, Rachel Spiering, Abul K. Abbas, Silke Appel, Rosa Bacchetta, Manuela Battaglia, David Berglund, Bruce Blazar, Jeffrey A. Bluestone, Martin Bornhäuser, Anja ten Brinke, Todd M. Brusko, Nathalie Cools, Maria Cristina Cuturi, Edward Geissler, Nick Giannoukakis, Karolina Gołab, David A. Hafler, S. Marieke van Ham, Joanna Hester, Keli Hippen, Mauro Di Ianni, Natasa Ilic, John Isaacs, Fadi Issa, Dorota Iwaszkiewicz-Grześ, Elmar Jaeckel, Irma Joosten, David Klatzmann, Hans Koenen, Cees van Kooten, Olle Korsgren, Karsten Kretschmer, Megan Levings, Natalia Maria Marek-Trzonkowska, Marc Martinez-Llordella, Djordje Miljkovic, Kingston H.G. Mills, Joana P. Miranda, Ciriaco A. Piccirillo, Amy L. Putnam, Thomas Ritter, Maria Grazia Roncarolo, Shimon Sakaguchi, Silvia Sánchez-Ramón, Birgit Sawitzki, Ljiljana Sofronic-Milosavljevic, Megan Sykes, Qizhi Tang, Marta Vives-Pi, Herman Waldmann, Piotr Witkowski, Kathryn J. Wood, Silvia Gregori, Catharien M. U. Hilkens, Giovanna Lombardi, Phillip Lord, Eva M. Martinez-Caceres, Piotr Trzonkowski
Publikováno v:
Frontiers in Immunology, Vol 8 (2018)
Cellular therapies with CD4+ T regulatory cells (Tregs) hold promise of efficacious treatment for the variety of autoimmune and allergic diseases as well as posttransplant complications. Nevertheless, current manufacturing of Tregs as a cellular medi
Externí odkaz:
https://doaj.org/article/6e6307c0ff3e4a65bfd0edfff5a979c4
Autor:
Małgorzata Grzywińska, Anna Jaźwińska-Curyłło, Kamil Chwojnicki, Paulina Glasner, Marlena Kubach, Maciej Zieliński, Piotr Trzonkowski, Aleksandra Konarzewska, Kamil Kowalczyk, Paweł Łowiec, Walenty M. Nyka, Justyna Sakowska, Dorota Iwaszkiewicz-Grześ, Julia Kulczycka, Anna Jankowska, Bartosz Karaszewski, Edyta Szurowska, Mateusz Gliwiński
Publikováno v:
BioDrugs. 35:47-60
Multiple sclerosis (MS) is an immune-mediated disease in which autoimmune T conventional (Tconv) cells break the blood–brain barrier and destroy neurons of the central nervous system. It is hypothesized that CD4+CD25highCD127−FoxP3+ T regulatory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c44c795ce19d23d08d066b2782667f8
https://doi.org/10.1007/s40259-020-00462-7
https://doi.org/10.1007/s40259-020-00462-7
Autor:
Maciej, Zieliński, Magdalena, Żalińska, Dorota, Iwaszkiewicz-Grześ, Mateusz, Gliwiński, Matylda, Hennig, Anna, Jaźwińska-Curyłło, Halla, Kamińska, Justyna, Sakowska, Anna, Wołoszyn-Durkiewicz, Radosław, Owczuk, Wojciech, Młynarski, Przemysława, Jarosz-Chobot, Artur, Bossowski, Agnieszka, Szadkowska, Janusz, Siebert, Małgorzata, Myśliwiec, Natalia, Marek-Trzonkowska, Piotr, Trzonkowski
Publikováno v:
Diabetes, obesitymetabolismREFERENCES. 24(8)
Monotherapy with autologous expanded CD4We conducted a three-arms clinical trial to explore the efficacy and safety of the combined treatment with Tregs and rituximab in paediatric patients with T1DM. The patients were allocated to three groups: Treg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::186996e0d3d35fc81786082f538c5939
https://pubmed.ncbi.nlm.nih.gov/35441440
https://pubmed.ncbi.nlm.nih.gov/35441440
Autor:
Natalia Marek-Trzonkowska, Magdalena Piotrowska, Dorota Iwaszkiewicz-Grzes, Mateusz Gliwiński, Piotr Trzonkowski, Anne Eugster, Andreas Dahl
Publikováno v:
Cytotherapy. 22:629-641
Background: In recent years, therapies with CD4+CD25highFoxP3+ regulatory T cells (Tregs) have been successfully tested in many clinical trials. The important issue regarding the use of this treatment in autoimmune conditions remains the specificity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::443d6d29617f4b4ed8bb0851eacc325a
https://doi.org/10.1016/j.jcyt.2020.07.001
https://doi.org/10.1016/j.jcyt.2020.07.001
Autor:
null Maciej Zieliński, null Magdalena Żalińska, null Dorota Iwaszkiewicz‐Grześ, null Mateusz Gliwiński, null Matylda Hennig, null Anna Jaźwińska‐Curyłło, null Halla Kamińska, null Justyna Sakowska, null Anna Wołoszyn‐Durkiewicz, null Radosław Owczuk, null Wojciech Młynarski, null Przemysława Jarosz‐Chobot, null Artur Bossowski, null Agnieszka Szadkowska, null Janusz Siebert, null Małgorzata Myśliwiec, null Natalia Marek‐Trzonkowska, null Piotr Trzonkowski
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69234e8e3ad5c0bf4f0dc4b2a98d722b
https://doi.org/10.1111/dom.14723/v2/response1
https://doi.org/10.1111/dom.14723/v2/response1
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 7144, p 7144 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 7144, p 7144 (2021)
Regulatory T cells (Tregs) exert a highly suppressive function in the immune system. Disturbances in their function predispose an individual to autoimmune dysregulation, with a predominance of the pro-inflammatory environment. Besides Foxp3, which is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::847ce34b0a603165955eeba4bcf5de12
http://europepmc.org/articles/PMC8267835
http://europepmc.org/articles/PMC8267835